6.97
price down icon16.02%   -1.33
pre-market  Vorhandelsmarkt:  7.19   0.22   +3.16%
loading
Schlusskurs vom Vortag:
$8.30
Offen:
$6.92
24-Stunden-Volumen:
137.87K
Relative Volume:
3.71
Marktkapitalisierung:
$96.11M
Einnahmen:
$49.98M
Nettoeinkommen (Verlust:
$-9.64M
KGV:
-9.8169
EPS:
-0.71
Netto-Cashflow:
$-4.86M
1W Leistung:
+5.45%
1M Leistung:
+6.90%
6M Leistung:
-24.49%
1J Leistung:
+39.40%
1-Tages-Spanne:
Value
$6.86
$7.6336
1-Wochen-Bereich:
Value
$6.325
$8.74
52-Wochen-Spanne:
Value
$3.75
$11.99

Champions Oncology Inc Stock (CSBR) Company Profile

Name
Firmenname
Champions Oncology Inc
Name
Telefon
410-369-0365
Name
Adresse
855 N. WOLFE STREET, BALTIMORE, NJ
Name
Mitarbeiter
306
Name
Twitter
@ChampsOnco
Name
Nächster Verdiensttermin
2025-09-15
Name
Neueste SEC-Einreichungen
Name
CSBR's Discussions on Twitter

Vergleichen Sie CSBR mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
CSBR
Champions Oncology Inc
6.97 114.44M 49.98M -9.64M -4.86M -0.71
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
391.36 100.82B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
461.24 60.45B 2.46B -319.09M -52.09M -2.47
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
575.06 60.69B 14.21B 4.46B 3.56B 39.68
Biotechnology icon
ARGX
Argen X Se Adr
752.32 46.32B 3.06B 1.28B 447.35M 21.30
Biotechnology icon
ONC
Beone Medicines Ltd Adr
327.20 36.58B 3.81B -644.79M -669.77M -6.24

Champions Oncology Inc Stock (CSBR) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2024-09-12 Hochstufung Craig Hallum Hold → Buy
2019-11-18 Eingeleitet The Benchmark Company Speculative Buy

Champions Oncology Inc Aktie (CSBR) Neueste Nachrichten

pulisher
01:31 AM

Is a relief rally coming for Champions Oncology Inc. holders2025 Price Targets & Advanced Swing Trade Entry Alerts - newser.com

01:31 AM
pulisher
01:12 AM

How sentiment analysis helps forecast Champions Oncology Inc.Weekly Profit Summary & Stepwise Trade Execution Plans - newser.com

01:12 AM
pulisher
Sep 16, 2025

Is Champions Oncology Inc. stock ready for a breakout2025 Market Sentiment & Community Consensus Trade Alerts - newser.com

Sep 16, 2025
pulisher
Sep 16, 2025

How to monitor Champions Oncology Inc. with trend dashboardsQuarterly Earnings Summary & Precise Buy Zone Identification - newser.com

Sep 16, 2025
pulisher
Sep 16, 2025

The Market Lifts Champions Oncology, Inc. (NASDAQ:CSBR) Shares 27% But It Can Do More - simplywall.st

Sep 16, 2025
pulisher
Sep 16, 2025

Champions Oncology Reports Steady Revenue and New Leadership - TipRanks

Sep 16, 2025
pulisher
Sep 16, 2025

Champions Oncology Inc (CSBR) Q1 2026 Earnings Call Highlights: Revenue Rebound and Strategic ... By GuruFocus - Investing.com Canada

Sep 16, 2025
pulisher
Sep 16, 2025

Live market analysis of Champions Oncology Inc.Weekly Trade Report & Verified Chart Pattern Signals - newser.com

Sep 16, 2025
pulisher
Sep 16, 2025

Guidance Update: Will Champions Oncology Inc benefit from geopolitical trendsVolume Spike & Real-Time Stock Movement Alerts - خودرو بانک

Sep 16, 2025
pulisher
Sep 15, 2025

Movement Recap: Is Champions Oncology Inc showing insider buyingQuarterly Profit Report & Accurate Entry and Exit Point Alerts - خودرو بانک

Sep 15, 2025
pulisher
Sep 15, 2025

Earnings call transcript: Champions Oncology Q1 2026 beats EPS expectations - Investing.com

Sep 15, 2025
pulisher
Sep 15, 2025

Aug Technicals: Does Champions Oncology Inc have strong fundamentalsStop Loss & Risk Managed Investment Strategies - خودرو بانک

Sep 15, 2025
pulisher
Sep 15, 2025

Champions Oncology Inc reports results for the quarter ended July 31Earnings Summary - TradingView

Sep 15, 2025
pulisher
Sep 15, 2025

Champions Oncology falls after slight revenue miss in first quarter By Investing.com - Investing.com Nigeria

Sep 15, 2025
pulisher
Sep 15, 2025

Champions Oncology falls after slight revenue miss in first quarter - Investing.com

Sep 15, 2025
pulisher
Sep 15, 2025

Champions Oncology Reports Quarterly Revenue of $14.0 Million - TradingView

Sep 15, 2025
pulisher
Sep 15, 2025

CHAMPIONS ONCOLOGY, INC. SEC 10-Q Report - TradingView

Sep 15, 2025
pulisher
Sep 15, 2025

CORRECTION: Champions Oncology Reports Quarterly Revenue of $14.0 Million - ACCESS Newswire

Sep 15, 2025
pulisher
Sep 15, 2025

Oncology Research Leader Champions Reports $14M Revenue as New CEO Rob Brainin Sets Growth Strategy - Stock Titan

Sep 15, 2025
pulisher
Sep 15, 2025

Champions Oncology Reports Record Quarterly Revenue of $14.0 Million - ACCESS Newswire

Sep 15, 2025
pulisher
Sep 15, 2025

Oncology Research Leader Champions Reports $14M Revenue as New CEO Rob Brainin Charts Growth Strategy - Stock Titan

Sep 15, 2025
pulisher
Sep 15, 2025

How to interpret RSI for Champions Oncology Inc. stockWeekly Profit Report & Long-Term Capital Growth Ideas - newser.com

Sep 15, 2025
pulisher
Sep 15, 2025

Bank Watch: Does Champions Oncology Inc stock have upside surprise potential2025 Winners & Losers & Low Drawdown Investment Strategies - خودرو بانک

Sep 15, 2025
pulisher
Sep 14, 2025

Is Champions Oncology Inc. forming a bottoming baseJuly 2025 EndofMonth & Weekly Top Gainers Alerts - newser.com

Sep 14, 2025
pulisher
Sep 14, 2025

is champions oncology inc. stock ready for a breakoutMarket Trend Review & Safe Capital Preservation Plans - newser.com

Sep 14, 2025
pulisher
Sep 14, 2025

Will Champions Oncology Inc. stock recover after recent dropMarket Growth Report & Weekly High Potential Stock Alerts - newser.com

Sep 14, 2025
pulisher
Sep 14, 2025

Using flow based indicators on Champions Oncology Inc.Quarterly Market Review & Verified Technical Trade Signals - newser.com

Sep 14, 2025
pulisher
Sep 14, 2025

Advanced analytics toolkit walkthrough for Champions Oncology Inc.Quarterly Market Summary & Weekly Stock Breakout Alerts - newser.com

Sep 14, 2025
pulisher
Sep 12, 2025

Smart tools for monitoring Champions Oncology Inc.’s price actionJuly 2025 Retail & Advanced Technical Signal Analysis - Newser

Sep 12, 2025
pulisher
Sep 12, 2025

Tools to monitor Champions Oncology Inc. recovery probabilityDollar Strength & Fast Gain Stock Trading Tips - Newser

Sep 12, 2025
pulisher
Sep 12, 2025

Visual trend scoring systems applied to Champions Oncology Inc.July 2025 Action & AI Enhanced Trading Alerts - Newser

Sep 12, 2025
pulisher
Sep 12, 2025

Will Champions Oncology Inc. stock outperform value stocksJuly 2025 Intraday Action & Community Shared Stock Ideas - baoquankhu1.vn

Sep 12, 2025
pulisher
Sep 12, 2025

Champions Oncology Inc expected to post a loss of 1 cent a shareEarnings Preview - TradingView

Sep 12, 2025
pulisher
Sep 12, 2025

Champions Oncology Inc. stock prediction for this week2025 Technical Overview & Stepwise Trade Signal Implementation - Newser

Sep 12, 2025
pulisher
Sep 12, 2025

Will Champions Oncology Inc. price bounce be sustainableMarket Trend Summary & Daily Momentum Trading Reports - Newser

Sep 12, 2025
pulisher
Sep 12, 2025

Can Champions Oncology Inc. recover in the next quarterJuly 2025 Catalysts & Verified Momentum Stock Ideas - Newser

Sep 12, 2025
pulisher
Sep 12, 2025

Technical signs of recovery in Champions Oncology Inc.Portfolio Value Report & Fast Moving Stock Trade Plans - Newser

Sep 12, 2025
pulisher
Sep 12, 2025

Chart based analysis of Champions Oncology Inc. trends2025 Biggest Moves & AI Powered Buy and Sell Recommendations - Newser

Sep 12, 2025
pulisher
Sep 12, 2025

What momentum shifts mean for Champions Oncology Inc.2025 Bull vs Bear & AI Forecasted Stock Moves - Newser

Sep 12, 2025
pulisher
Sep 12, 2025

Signal strength of Champions Oncology Inc. stock in tech scannersWeekly Earnings Recap & Risk Adjusted Buy/Sell Alerts - Newser

Sep 12, 2025
pulisher
Sep 12, 2025

Using economic indicators to assess Champions Oncology Inc. potential2025 Earnings Impact & Capital Protection Trading Alerts - Newser

Sep 12, 2025
pulisher
Sep 12, 2025

Visualizing Champions Oncology Inc. stock with heatmaps2025 Dividend Review & Breakout Confirmation Trade Signals - Newser

Sep 12, 2025

Finanzdaten der Champions Oncology Inc-Aktie (CSBR)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$35.42
price up icon 0.77%
$83.90
price up icon 0.91%
$28.24
price up icon 0.89%
$99.26
price up icon 1.41%
$144.75
price up icon 1.12%
biotechnology ONC
$327.20
price down icon 1.53%
Kapitalisierung:     |  Volumen (24h):